JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 29, 2006; DOI: 10.1124/jpet.106.107755


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.107755v1
320/1/274    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sprague, J. E.
Right arrow Articles by Mills, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sprague, J. E.
Right arrow Articles by Mills, E.


Received for publication May 12, 2006.
Revised September 28, 2006.
Accepted for publication September 28, 2006.

Roles of norepinephrine, free fatty acids, thyroid status and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis

Jon E. Sprague 1, Xianmei Yang 2, Joni Summers 1, Traci Gilman 3, Edward Mills 2*

1 Ohio Northern University 2 University of Texas at Austin 3 Virginia College of Osteopathic Medicine

* Address correspondence to: E-mail: ted_mills{at}mail.utexas.edu

Abstract

Thyroid hormone (TH) plays a fundamental role in thermoregulation yet the molecular mediators of its effects are not fully defined. Recently, skeletal muscle (SKM) uncoupling protein 3 (UCP3) was shown to be an important mediator of the thermogenic effects of the widely abused sympathomimetic agents 3,4-methlyenedioxymeth-amphetamine (MDMA, Ecstasy) and methamphetamine. Expression of UCP3 is regulated by TH. Activation of UCP3 is indirectly regulated by norepinephrine (NE) and is dependent upon the availability of free fatty acids (FFAs). We hypothesized that UCP3 may be a molecular link between TH and hyperthermia, requiring increased levels of both NE and FFAs to accomplish the thermogenic effect. Here, we demonstrate that MDMA (40 mg/kg, sc) significantly increases plasma FFA levels 30 minutes after treatment. Pharmacologically increasing NE levels through the inhibition of phenylethanolamine N-methyltransferase with ±2,3-dichloro-{alpha}-methylbenzylamine (DCMB) potentiated the hyperthermic effects of a 20 mg/kg dose of MDMA. Using Western blots and regression analysis, we further illustrated that chronic hyperthyroidism in rats potentiates the hyperthermic effects of MDMA and increases levels of SKM UCP3 protein in a linear fashion according to levels of circulating plasma TH. Conversely, chronic hypothyroidism results in a hypothermic response to MDMA which is directly proportionate to decreased UCP3 expression. Acute TH supplementation did not change the skeletal muscle UCP3 expression levels or temperature responses to MDMA. These findings suggest that, although MDMA-induced hyperthermia appears to result from increased NE and FFA levels, susceptibility is ultimately determined by TH regulation of UCP3-dependent thermogenesis.


Key words: MDMA, hyperthermia, norepinephrine, skeletal muscle, thyroid hormone, uncoupling proteins


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. E. Rusyniak, M. V. Zaretskaia, D. V. Zaretsky, and J. A. DiMicco
3,4-Methylenedioxymethamphetamine- and 8-Hydroxy-2-di-n-propylamino-tetralin-Induced Hypothermia: Role and Location of 5-Hydroxytryptamine 1A Receptors
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 477 - 487.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.